Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP227385.RA-buws6cSpYxYKB3zCQ-CH2RN5lsZqE3QwGj10EF2mew130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP227385.RA-buws6cSpYxYKB3zCQ-CH2RN5lsZqE3QwGj10EF2mew130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP227385.RA-buws6cSpYxYKB3zCQ-CH2RN5lsZqE3QwGj10EF2mew130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP227385.RA-buws6cSpYxYKB3zCQ-CH2RN5lsZqE3QwGj10EF2mew130_provenance.
- NP227385.RA-buws6cSpYxYKB3zCQ-CH2RN5lsZqE3QwGj10EF2mew130_assertion description "[The results of this study suggest that NLK is aberrantly regulated in HCC, which might contribute to the mitogenic potential of tumor cells during the initiation and progression of hepatocellular carcinoma; this process appears to involve the induction of CDK2 and cyclin D1 and might provide a novel target for therapeutic intervention in patients with liver cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP227385.RA-buws6cSpYxYKB3zCQ-CH2RN5lsZqE3QwGj10EF2mew130_provenance.
- NP227385.RA-buws6cSpYxYKB3zCQ-CH2RN5lsZqE3QwGj10EF2mew130_assertion evidence source_evidence_literature NP227385.RA-buws6cSpYxYKB3zCQ-CH2RN5lsZqE3QwGj10EF2mew130_provenance.
- NP227385.RA-buws6cSpYxYKB3zCQ-CH2RN5lsZqE3QwGj10EF2mew130_assertion SIO_000772 20512928 NP227385.RA-buws6cSpYxYKB3zCQ-CH2RN5lsZqE3QwGj10EF2mew130_provenance.
- NP227385.RA-buws6cSpYxYKB3zCQ-CH2RN5lsZqE3QwGj10EF2mew130_assertion wasDerivedFrom befree-20140225 NP227385.RA-buws6cSpYxYKB3zCQ-CH2RN5lsZqE3QwGj10EF2mew130_provenance.
- NP227385.RA-buws6cSpYxYKB3zCQ-CH2RN5lsZqE3QwGj10EF2mew130_assertion wasGeneratedBy ECO_0000203 NP227385.RA-buws6cSpYxYKB3zCQ-CH2RN5lsZqE3QwGj10EF2mew130_provenance.
- befree-20140225 importedOn "2014-02-25" NP227385.RA-buws6cSpYxYKB3zCQ-CH2RN5lsZqE3QwGj10EF2mew130_provenance.